Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia - Price - 2020 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Lestaurtinib, JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor (ab142107) is not available
File:Regorafenib.svg - Wikipedia
JPM | Free Full-Text | Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
New Drug Approvals 2012 - Pt. XXI - Regorafenib (Stivarga®)
Regorafenib: Uses, Interactions, Mechanism of Action | DrugBank Online
O2k-Publications: CIV - Bioblast
New Drug Approvals 2012 - Pt. XXI - Regorafenib (Stivarga®)
REGORAFENIB ANHYDROUS
Glucocorticoid-induced microRNA-378 signaling mediates the progression of pancreatic cancer by enhancing autophagy | Cell Death & Disease
Regorafenib Impurity 10 2098799-12-1 wiki
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors | Nature Communications
JPM | Free Full-Text | Promoting Precision Cancer Medicine through a Community-Driven Knowledgebase
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Rifampicin 13292-46-1 wiki
Role of Tyrosine Kinase in cancer | PPT
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Cyclodextrin News
Frontiers | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma
Regorafenib 755037-03-7 wiki
Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. - Abstract - Europe PMC
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib | C21H15ClF4N4O3 | CID 11167602 - PubChem
Regorafenib 755037-03-7 wiki
File:Systemic targeted therapy options for intermediate and advanced HCC.png - Wikimedia Commons
PharmaWiki - Regorafenib
Regorafenib | C21H15ClF4N4O3 | ChemSpider
